TECH
Bio-Techne Corporation (TECH)
NASDAQ · Healthcare
Bio-Techne Corporation annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bio-Techne Corporation revenue for the quarter ending March 31, 2026 was 311.4 M, a 1.51% decrease year-over-year.
- Bio-Techne Corporation revenue for the twelve months ending March 31, 2026 was 1.2 B, a 4.09% increase year-over-year.
- Bio-Techne Corporation annual revenue for 2025 was 1.2 B, a 5.23% increase from 2024.
- Bio-Techne Corporation annual revenue for 2024 was 1.2 B, a 1.97% increase from 2023.
- Bio-Techne Corporation annual revenue for 2023 was 1.1 B, a 2.81% increase from 2022.
- Bio-Techne Corporation annual revenue for 2022 was 1.1 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bio-Techne Corporation Market Cap — FAQ
Bio-Techne Corporation (TECH) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TECH's market cap history?
The chart and table above show Bio-Techne Corporation's market cap by year and by quarter, including the growth rate.